Provided by Tiger Fintech (Singapore) Pte. Ltd.

GE HEALTHCARE TECHNOLOGIES INC

75.96
-0.2800-0.37%
Post-market: 75.960.00000.00%19:44 EDT
Volume:3.38M
Turnover:256.94M
Market Cap:34.78B
PE:15.96
High:76.86
Open:76.84
Low:75.45
Close:76.24
Loading ...

GE's 3 Offspring Are All Grown Up and Making Waves. The Best Is Yet to Come. -- Barrons.com

Dow Jones
·
19 Jul

GE HealthCare Technologies Inc. Stock Rises Wednesday, Outperforms Market

Dow Jones
·
17 Jul

GE HealthCare Technologies Inc. Stock Rises Thursday, Outperforms Market

Dow Jones
·
11 Jul

GE Hlthcr Techs Is Maintained at Buy by Citigroup

Dow Jones
·
10 Jul

Citigroup Raises GE Healthcare Technologies Price Target to $89 From $86, Buy Rating Maintained

MT Newswires Live
·
10 Jul

GE HealthCare Technologies Inc. to Announce Second Quarter 2025 Financial Results

Reuters
·
07 Jul

Income Investing: The GE Stocks Are Paying Out Real Dividends Again -- Barron's

Dow Jones
·
05 Jul

ASX ALERT-Completion of Financial Requirements under GE HealthCare MOU-ENL.AX

Reuters
·
04 Jul

The GE Stocks Are Worth Owning for Their Dividends Again -- Barrons.com

Dow Jones
·
03 Jul

GE HealthCare Technologies (NasdaqGS:GEHC) Board Confirms US$0.04 Dividend for Q2 2025

Simply Wall St.
·
03 Jul

GE HealthCare Technologies Inc. Stock Rises Tuesday, Outperforms Market

Dow Jones
·
02 Jul

GE Healthcare Technologies Keeps Quarterly Dividend at $0.035 a Share; Payable Aug. 15 to Holders of Record as of July 25

MT Newswires Live
·
01 Jul

GE Healthcare Technologies Inc - Declares $0.035 per Share Dividend for Q2 2025

THOMSON REUTERS
·
01 Jul

GE Healthcare Announces Cash Dividend for Second Quarter of 2025

THOMSON REUTERS
·
01 Jul

Press Release: GE HealthCare announces cash dividend for second quarter of 2025

Dow Jones
·
01 Jul

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2025-06-26

Reuters
·
26 Jun

GE HealthCare Technologies Inc. Stock Rises Wednesday, Outperforms Market

Dow Jones
·
26 Jun

Inside Nvidia’s Investment Blueprint: Mapping the Next Empire of AI, Automation, and Infrastructure

TradingKey
·
25 Jun

FDA Approves Expanded Use of GE HealthCare's Vizamyl for Enhanced Alzheimer's Diagnosis and Monitoring

Reuters
·
25 Jun

FDA Approves Expanded Indications for GE Healthcare’s Vizamyl Pet Imaging Agent for Beta Amyloid Detection, Enabling More Precise Care for Alzheimer’s Patients

THOMSON REUTERS
·
25 Jun